Ae Wealth Management LLC T2 Biosystems, Inc. Transaction History

Ae Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$0.09 - $565.0 $1,350 - $8.48 Million	15,000 Added 40.54%	52,000 $6,000
Q1 2022 Apr 18, 2022	BUY	$0.36 - $0.57 $720 - $1,140	2,000 Added 5.71%	37,000 $19,000
Q4 2021 Jan 20, 2022	BUY	$0.46 - $0.94 $4,370 - $8,930	9,500 Added 37.25%	35,000 $18,000
Q3 2021 Nov 01, 2021	BUY	$0.86 - $1.21 $6,450 - $9,075	7,500 Added 41.67%	25,500 $23,000
Q2 2021 Jul 21, 2021	BUY	$1.04 - $1.69 $18,720 - $30,420	18,000 New	18,000 $21,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.